| ACADIA Pharmaceuticals News (2003-2004) |
 |
| Monday, June 16, 2008 |
| ACADIA Pharmaceuticals Announces Results from ACP-104 Phase Iib Schizophrenia Trial Posted 6:26 AM PST |
| |
| Wednesday, May 14, 2008 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Posted 8:14 AM PST |
| |
| Wednesday, April 30, 2008 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Posted 6:41 AM PST |
| |
| Wednesday, April 16, 2008 |
| ACADIA Pharmaceuticals to Present Data from Its Phase II Trial with Pimavanserin for Parkinson’s Disease Psychosis at the 60th American Academy of Neurology Annual Meeting 60th American Academy of Neurology Annual Meeting Posted 8:19 AM PST |
| |
| Friday, April 4, 2008 |
| ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104, ACP-105 and Its Muscarinic Discovery Program at Experimental Biology 2008 Meeting Posted 5:58 AM PST |
| |
| Monday, March 31, 2008 |
| ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson’s Disease Psychosis Posted 6:53 AM PST |
| |
| Tuesday, March 11, 2008 |
| ACADIA Pharmaceuticals to Present at Lehman Brothers 11th Annual Global Healthcare Conference Posted 7:34 AM PST |
| |
| Tuesday, February 12, 2008 |
| SAN DIEGO--- ACADIA Pharmaceuticals Appoints John J. Kaiser as Vice President, Strategic Marketing and Commercial Development Posted 8:01 AM PST |
| |
| Tuesday, February 5, 2008 |
| ACADIA Pharmaceuticals Announces Presentation of Data on Pimavanserin Co-Therapy at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders Posted 7:42 AM PST |
| |
| Monday, February 4, 2008 |
| ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 12th BIO CEO & Investor Conference 2008 Posted 7:42 AM PST |
| |
| Thursday, December 6, 2007 |
| ACADIA Pharmaceuticals to Webcast Its Analyst and Investor Meeting on December 14th Posted 7:48 AM PST |
| |
| Friday, November 2, 2007 |
| ACADIA Pharmaceuticals to Present Preclinical Data on Its Advanced Schizophrenia Programs at the 37th Annual Meeting of the Society for Neuroscience Posted 6:33 AM PST |
| |
| Friday, October 26, 2007 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Posted 6:57 AM PST |
| |
| Wednesday, October 3, 2007 |
| ACADIA Pharmaceuticals to Present at BIO InvestorForum 2007 on October 10, 2007 Posted 6:51 AM PST |
| |
| Tuesday, September 25, 2007 |
| ACADIA Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index Posted 7:08 AM PST |
| |
| Wednesday, September 19, 2007 |
| ACADIA Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference Posted 3:40 PM PST |
| |
| Monday, July 16, 2007 |
| ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate Posted 7:52 AM PST |
| |
| Tuesday, June 26, 2007 |
| ACADIA Pharmaceuticals Initiates Phase Iib Clinical Trial with ACP-104 in Patients with Schizophrenia Posted 9:58 AM PST |
| |
| Monday, June 11, 2007 |
| ACADIA Pharmaceuticals Initiates Phase III Trial with Pimavanserin in Patients with Parkinson’s Disease Psychosis Posted 6:43 AM PST |
| |
| Tuesday, May 8, 2007 |
| ACADIA Pharmaceuticals Reports First Quarter 2007 Financial Results Posted 5:07 PM PST |
| |
| Tuesday, May 1, 2007 |
| ACADIA Pharmaceuticals to Announce First Quarter 2007 Financial Results on May 8, 2007 Posted 8:16 AM PST |
| |
| Tuesday, April 24, 2007 |
| Pimavanserin Approved by USAN as Nonproprietary Name for ACADIA Drug Candidate ACP-103 Posted 7:36 AM PST |
| |
| Wednesday, April 4, 2007 |
| ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering Posted 6:47 PM PST |
| |
| Monday, April 2, 2007 |
| ACADIA Pharmaceuticals Announces Proposed Public Stock Offering Posted 7:46 AM PST |
| |
| Monday, March 19, 2007 |
| ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial Posted 5:04 AM PST |
| |
| Tuesday, February 27, 2007 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2006 Financial Results on March 6, 2007 Posted 7:29 AM PST |
| |
| Monday, December 4, 2006 |
| ACADIA Pharmaceuticals Adds Complementary Intellectual Property for Serotonin Platform Posted 7:39 AM PST |
| |
| Monday, November 6, 2006 |
| ACADIA Pharmaceuticals Reports Third Quarter 2006 Financial Results Posted 2:30 PM PST |
| |
| Monday, October 30, 2006 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2006 Financial Results on November 6, 2006 Posted 6:38 AM PST |
| |
| Monday, October 23, 2006 |
| ACADIA Pharmaceuticals to Support Launch of New Company Focused on Substance Abuse Therapeutics Posted 6:17 AM PST |
| |
| Wednesday, September 27, 2006 |
| SAN DIEGO--- CONNECT Announces 2006 Most Innovative New Product (MIP) Awards Finalists Posted 3:42 PM PST |
| |
| Monday, September 25, 2006 |
| ACADIA Pharmaceuticals Announces Accelerated Timing of ACP-103 Phase II Trial in Patients with Schizophrenia; Top-Line Results for Complete 400-Patient Study Expected in Q1 2007 Posted 5:37 AM PST |
| |
| Tuesday, August 8, 2006 |
| ACADIA Pharmaceuticals Reports Second Quarter 2006 Financial Results Posted 3:29 PM PST |
| |
| Thursday, July 13, 2006 |
| ACADIA Pharmaceuticals Announces Encouraging Results from Initial Clinical Trials with ACP-104 in Patients with Schizophrenia Posted 5:58 AM PST |
| |
| Monday, June 5, 2006 |
| SAN DIEGO--- ACADIA Pharmaceuticals Announces Appointment of Roger G. Mills, M.D., as Executive Vice President, Development Posted 8:24 AM PST |
| |
| Monday, May 15, 2006 |
| ACADIA Pharmaceuticals Added to NASDAQ Biotech Index Posted 8:02 AM PST |
| |
| Wednesday, May 10, 2006 |
| ACADIA Pharmaceuticals Reports First Quarter 2006 Financial Results Posted 2:38 PM PST |
| |
| Wednesday, May 3, 2006 |
| ACADIA Pharmaceuticals to Announce First Quarter 2006 Financial Results on May 10, 2006 Posted 8:32 AM PST |
| |
| Monday, April 24, 2006 |
| ACADIA Pharmaceuticals Announces Proposed Public Stock Offering Posted 8:17 AM PST |
| |
| Wednesday, April 19, 2006 |
| ACADIA Pharmaceuticals Announces Positive Clinical Trial Results Demonstrating That ACP-103 Increases Slow Wave Sleep Posted 8:15 AM PST |
| |
| Thursday, March 23, 2006 |
| ACADIA Pharmaceuticals Announces Positive Results From Phase II Trial of ACP-103 for Treatment-Induced Psychosis in Patients With Parkinson's Disease Posted 3:49 PM PST |
| |
| Wednesday, February 22, 2006 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2005 Results on March 1, 2006 Posted 7:31 AM PST |
| |
| Tuesday, February 21, 2006 |
| ACADIA Pharmaceuticals Announces Advancements in Two Preclinical Programs Posted 6:45 AM PST |
| |
| Tuesday, January 17, 2006 |
| SAN DIEGO--- ACADIA Pharmaceuticals Announces Additional $10 Million Equity Investment by Sepracor Posted 7:54 AM PST |
| |
| Monday, January 9, 2006 |
| SAN DIEGO--- ACADIA Pharmaceuticals Announces Appointment of David C. Furlano, Ph.D., as Vice President, Regulatory Affairs Posted 8:46 AM PST |
| |
| Thursday, December 15, 2005 |
| ACADIA Pharmaceuticals Discovers Novel Isoform-Selective Retinoic Acid Receptor Agonists Posted 8:05 AM PST |
| |
| Thursday, December 1, 2005 |
| ACADIA Pharmaceuticals Reports Results From Phase II Study of ACP-103 in Schizophrenia Patients With Haloperidol-Induced Akathisia Posted 9:48 AM PST |
| |
| Thursday, November 10, 2005 |
| Acadia Pharmaceuticals Reports Third Quarter 2005 Financial Results Posted 5:04 PM PST |
| |
| ACADIA Pharmaceuticals Announces Initial Results From Ongoing Single-Dose Clinical Trial of ACP-104 in Schizophrenia Patients Posted 5:04 PM PST |
| |
| Thursday, November 3, 2005 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2005 Financial Results on November 10, 2005 Posted 9:51 AM PST |
| |
| Tuesday, November 1, 2005 |
| ACADIA Pharmaceuticals to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 8, 2005 Posted 8:52 AM PST |
| |
| Monday, October 3, 2005 |
| ACADIA Pharmaceuticals Earns Milestone on Advancement of Neuropathic Pain Clinical Program Posted 9:05 AM PST |
| |
| Thursday, September 22, 2005 |
| ACADIA Pharmaceuticals Study Identifies Molecular Properties of ACP-104 That Predict Unique Antipsychotic Activity Posted 9:00 AM PST |
| |
| Friday, September 16, 2005 |
| ACADIA Pharmaceuticals Officially Opens New Chemistry R&D Facility in Sweden Posted 6:39 AM PST |
| |
| Tuesday, September 13, 2005 |
| SAN DIEGO--- ACADIA Pharmaceuticals Announces Election of Michael T. Borer to Board of Directors Posted 8:34 AM PST |
| |
| Wednesday, August 10, 2005 |
| ACADIA Pharmaceuticals Reports Second Quarter 2005 Financial Results Posted 4:44 PM PST |
| |
| Wednesday, August 3, 2005 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2005 Financial Results on August 10, 2005 Posted 9:18 AM PST |
| |
| Wednesday, June 22, 2005 |
| ACADIA Pharmaceuticals Announces Encouraging Interim Results From Ongoing Phase II Trial of ACP-103 for Treatment-Induced Psychosis in Patients With Parkinson's Disease Posted 7:57 AM PST |
| |
| Thursday, May 19, 2005 |
| ACADIA Pharmaceuticals to Present at the Fourth Annual Needham Biotechnology Conference Posted 9:20 AM PST |
| |
| Tuesday, May 17, 2005 |
| ACADIA Pharmaceuticals Expands Technology Platform to Target Tyrosine Kinase Linked Receptors Posted 8:42 AM PST |
| |
| Wednesday, May 11, 2005 |
| ACADIA Pharmaceuticals Reports First Quarter 2005 Financial Results Posted 5:57 PM PST |
| |
| Tuesday, May 10, 2005 |
| ACADIA Pharmaceuticals to Present at Banc of America Securities Health Care Conference 2005 Posted 9:02 AM PST |
| |
| Wednesday, May 4, 2005 |
| ACADIA Pharmaceuticals to Announce First Quarter 2005 Financial Results on May 11, 2005 Posted 8:52 AM PST |
| |
| Thursday, April 28, 2005 |
| SAN DIEGO--- ACADIA Pharmaceuticals Announces Election of Mary Ann Gray, Ph.D. to Board of Directors Posted 9:56 AM PST |
| |
| Friday, April 15, 2005 |
| SAN DIEGO--- ACADIA Pharmaceuticals Announces $36 Million Financing Posted 5:13 PM PST |
| |
| Monday, March 7, 2005 |
| SAN DIEGO--- ACADIA Announces Management Appointments in Business Development and Research and Development Posted 8:51 AM PST |
| |
| Thursday, March 3, 2005 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2004 Posted 5:43 PM PST |
| |
| Thursday, February 24, 2005 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2004 Financial Results on March 3, 2005 Posted 11:11 AM PST |
| |
| Tuesday, February 22, 2005 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences Posted 10:30 AM PST |
| |
| Thursday, February 17, 2005 |
| ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 24, 2005 Posted 11:40 AM PST |
| |
| Wednesday, January 19, 2005 |
| ACADIA Pharmaceuticals to Present at the Piper Jaffray 17th Annual Health Care Conference on January 26, 2005 Posted 6:49 PM PST |
| |
| Tuesday, January 11, 2005 |
| ACADIA Pharmaceuticals Announces Partnership With Sepracor Posted 10:51 AM PST |
| |
| Thursday, September 2, 2004 |
| ACADIA Pharmaceuticals to Expand Scandinavian Chemistry Operations Posted 8:59 AM PST |
| |
| Wednesday, August 11, 2004 |
| ACADIA Pharmaceuticals Reports Second Quarter 2004 Financial Results Posted 4:46 PM PST |
| |
| Thursday, August 5, 2004 |
| ACADIA Pharmaceuticals Inc. Second Quarter 2004 Earnings Conference Call Posted 8:59 AM PST |
| |
| ACADIA Pharmaceuticals to Announce Second Quarter 2004 Financial Results on August 11, 2004 Posted 8:51 AM PST |
| |
| Tuesday, August 3, 2004 |
| ACADIA Study Links ACP-104 (N-desmethylclozapine) to Improved Cognition in Schizophrenia Patients Posted 9:15 AM PST |
| |
| Thursday, May 27, 2004 |
| SAN DIEGO--- ACADIA Pharmaceuticals Announces Initial Public Offering Posted 8:48 AM PST |
| |
| Friday, February 27, 2004 |
| Acadia Pharmaceuticals Inc. Files Registration Statement For Initial Public Offering Posted 5:12 PM PST |
| |
| Thursday, January 8, 2004 |
| ACADIA Pharmaceuticals Achieves Milestone as Allergan Advances Glaucoma Drug Candidate Posted 9:14 AM PST |
| |
| Thursday, June 12, 2003 |
| ACADIA Pharmaceuticals Expands Private Placement to $28 Million Posted 7:57 AM PST |
| |
| Tuesday, April 15, 2003 |
| Allergan and ACADIA Pharmaceuticals Announce New Drug Discovery and Development Collaboration Posted 7:02 AM PST |
| |
| Friday, March 28, 2003 |
| ACADIA Pharmaceuticals Completes $25 Million Private Placement Posted 7:25 AM PST |
| |
| Wednesday, January 22, 2003 |
| ACADIA Initiates Clinical Trials for ACP-103 - Initially Targets Treatment-Induced Dysfunction in Parkinson's Disease Posted 8:11 AM PST |
| |
